rs36119840
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000514.4(GDNF):c.277C>T(p.Arg93Trp) variant causes a missense change. The variant allele was found at a frequency of 0.00357 in 1,613,822 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0026 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0037 ( 15 hom. )
Consequence
GDNF
NM_000514.4 missense
NM_000514.4 missense
Scores
4
6
4
Clinical Significance
Conservation
PhyloP100: 4.16
Genes affected
GDNF (HGNC:4232): (glial cell derived neurotrophic factor) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. The recombinant form of this protein, a highly conserved neurotrophic factor, was shown to promote the survival and differentiation of dopaminergic neurons in culture, and was able to prevent apoptosis of motor neurons induced by axotomy. This protein is a ligand for the product of the RET (rearranged during transfection) protooncogene. Mutations in this gene may be associated with Hirschsprung disease and Tourette syndrome. This gene encodes multiple protein isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.0073699653).
BP6
?
Variant 5-37816010-G-A is Benign according to our data. Variant chr5-37816010-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 8758.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-37816010-G-A is described in Lovd as [Likely_benign].
BS2
?
High AC in GnomAd at 402 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GDNF | NM_000514.4 | c.277C>T | p.Arg93Trp | missense_variant | 3/3 | ENST00000326524.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GDNF | ENST00000326524.7 | c.277C>T | p.Arg93Trp | missense_variant | 3/3 | 1 | NM_000514.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00264 AC: 402AN: 152196Hom.: 2 Cov.: 33
GnomAD3 genomes
?
AF:
AC:
402
AN:
152196
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00225 AC: 566AN: 251340Hom.: 1 AF XY: 0.00230 AC XY: 313AN XY: 135848
GnomAD3 exomes
AF:
AC:
566
AN:
251340
Hom.:
AF XY:
AC XY:
313
AN XY:
135848
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00367 AC: 5365AN: 1461508Hom.: 15 Cov.: 33 AF XY: 0.00355 AC XY: 2583AN XY: 727000
GnomAD4 exome
AF:
AC:
5365
AN:
1461508
Hom.:
Cov.:
33
AF XY:
AC XY:
2583
AN XY:
727000
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00264 AC: 402AN: 152314Hom.: 2 Cov.: 33 AF XY: 0.00220 AC XY: 164AN XY: 74486
GnomAD4 genome
?
AF:
AC:
402
AN:
152314
Hom.:
Cov.:
33
AF XY:
AC XY:
164
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
22
ALSPAC
AF:
AC:
16
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
28
ExAC
?
AF:
AC:
268
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hirschsprung disease, susceptibility to, 3 Benign:2Other:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 03, 2022 | - - |
risk factor, no assertion criteria provided | literature only | OMIM | Apr 01, 2003 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 23, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | GDNF: BS2 - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 10, 2014 | Arg110Trp in exon 3 of GDNF: This variant has been reported in individuals with various phenotypes including pulmonary presentations (see below). However, it i s not expected to cause disease on its own because it has been identified in 0.3 % (28/8600) of European American chromosomes by the NHLBI Exome Sequencing Proje ct (http://evs.gs.washington.edu/EVS/; dbSNP rs36119840). Phenotypes of individu als reported to carry this variant include isolated congenital central hypoventi lation syndrome, sporadic pheochromocytoma, Hirschsprung disease, and congenital anomalies of the kidney or urinary tract (reported as Arg93Trp; Angrist 1996, S olomon 1996, Woodward 1997, Amiel 1998, Amiel 2003, Chatterjee 2012). In vitro f unctional studies provide some evidence that the Arg110Trp variant may not impac t protein function (reported as Arg93Trp; Eketjall 2002). In summary, this varia nt is not expected to be disease-causing when seen in isolation, though a modify ing role cannot be fully excluded. - |
GDNF-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 22, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
Cadd
Pathogenic
Dann
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;.
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Pathogenic
D
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Benign
T
Sift4G
Uncertain
D;D;D;D;D;D
Polyphen
1.0, 1.0
.;D;D;D;D;D
Vest4
MVP
MPC
1.4
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at